ClinicalTrials.govpublic full text
Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]
hepatitis c, chronic, directly observed therapy, sofosbuvir, daclatasvir, pegylated interferon, resource-limited setting, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885184
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.